InsiderClue
← All stocks

MEDICINOVA INC

MNOV Net buying
CIK 0001226616 #4567 in the set updated 22 Sep 2026
Bought (120 mo)
$235.57K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$51.23K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$51.23K
6 of 6 sales
Net
+$184.34K
+$184.34K against sales at will

By person

7 insiders · 42 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kobayashi Yutaka
Director
$140.48K (2)
—
+$140.48K
106,800
0.2170%
$240.30K
+30.6%
IWAKI YUICHI
President and CEO
$62.00K (1)
—
+$62.00K
1,091,933
2.22%
$2.46M
+47.0%
Nagao Hideki
Director
—
$51.23K (6)
−$51.23K
0
0.0000%
$0.00
—
Ishizaka Yoshio
Director
$25.85K (1)
—
+$25.85K
15,000
0.0305%
$33.75K
+50.0%
Matsuda Kazuko
Chief Medical Officer
$7.24K (1)
—
+$7.24K
322,996
0.6562%
$726.74K
+344.0%
Okajima Masatsune
VP and Head of Japanese Office
—
—
—
1,040,530
2.11%
$2.34M
+1,517%
OBrien Geoffrey
Vice President
—
—
—
48,318
0.0982%
$108.72K
+866.4%

Individual transactions

5
Insider
Date
Role
Action
Shares
Price
Amount
Matsuda Kazuko
13 Mar 2020
Chief Medical Officer
Buy
2,000
$3.62
$7.24K
IWAKI YUICHI
12 Mar 2020
President and CEO
Buy
20,000
$3.10
$62.00K
Ishizaka Yoshio
21 Aug 2017
Director
Buy indirect
5,000
$5.17
$25.85K
Kobayashi Yutaka
15 May 2017
Director
Buy indirect
1,000
$5.60
$5.60K
Kobayashi Yutaka
12 May 2017
Director
Buy indirect
24,000
$5.62
$134.88K
Show all 42 transactions →

What was left out

Form 4 filings counted 93
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 1,613,023
Sales filed before the plan box existed 6
History held since 9 Sep 2016